Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings Routine +

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

First net income and record EBITDA beat expectations, but same-store sales decline and flat price action suggest skepticism remains.

By The Northwire Desk — AI Analysis Jun 15, 2026 · 16:00 HITI · 3.23 High Tide Inc.
Executive Summary
  • Q2 FY2026 revenue reached $179.3M (+30% YoY, +1% QoQ).
  • Adjusted EBITDA hit a record $13.9M (+73% YoY).
  • Company reported its first positive net income ($0.024M), reversing a $2.8M loss YoY.
  • Free cash flow generated was $1.5M, down from $4.9M YoY due to working capital investments.
  • Consolidated gross margin reached 27%, an eight-quarter high (+200 bps QoQ).
  • Remexian (German medical cannabis) generated record segment revenue of $31.6M (+49% YoY) with gross margins doubling to 27% from 12% in Q1.
  • Canna Cabana retail same-store sales declined 1.2% YoY but outperformed peers; shrink improved to 0.2%.
  • Secured a $40M senior secured credit facility from Bank of Montreal to refinance existing debt and fund growth.
  • Acquired Northern Helm for $7.74M (4 Ontario stores) at 4.5x annualized adjusted EBITDA.
  • Insiders purchased 90,882 shares at an average of $3.39.
Material Impact
  • The news is positive but routine. The record EBITDA beat and first net income are operationally sound, driven by the Remexian margin expansion and cost controls. However, the 1.2% decline in same-store sales signals potential retail saturation or competitive pressure in Canada. The stock's -3.9% move into the print indicates skepticism was already discounted. The market likely viewed the retail top-line deceleration as a drag that offsets the EBITDA beat. There is no fundamentally new catalyst to re-rate the business; the execution is steady but not transformative.
HITI · Price
Company Overview
  • High Tide operates Canna Cabana, the largest cannabis retail chain in Canada with 221 locations, and Remexian Pharma, a leading medical cannabis distributor in Germany. The company leverages a membership ecosystem (Cabana Club and ELITE) and a discount club model to drive customer loyalty and market share. It is also exploring expansion into the U.K. and U.S. CBD markets.
Read the original news release →

More from High Tide Inc.

Jun 17, 2026 · 06:00

Remexian distribution partnerships reinforce German growth thesis, but stock has already priced in the catalyst.

M&A / Property Jun 15, 2026 · 15:31

High Tide receives approval for $40M of facilities

Financings Jun 15, 2026 · 06:00

High Tide to Acquire Northern Helm, Adding Four Established Retail Cannabis Stores in Ontario

M&A / Property Jun 10, 2026 · 11:00

Routine store expansion in line with guidance; market remains skeptical as stock drifts lower post-Q1 beat.

Production / Operations May 11, 2026 · 06:00

Insider buying and surging German medical cannabis market share signal conviction as High Tide shores up a Big Five bank credit line.

Production / Operations May 06, 2026 · 06:00

High Tide Germany Distribution Surges as Bank Financing Validates Liquidity

Production / Operations